\n<\/p>\n
The dangers of fatty liver disease may not be well known around the globe, but it\u2019s a serious health condition. International researchers\u00a0estimate\u00a0that nonalcoholic fatty liver disease (NAFLD) is the most common liver disease, with a worldwide prevalence of 25%.<\/p>\n
The disease involves an increased build-up of fat in the liver, and in extreme cases, it can result in liver failure. Symptoms include fatigue, weight loss, and abdominal pain.<\/p>\n
Researchers in China recently explored the relationship between cannabis use and liver steatosis, and the results of the analysis are significant. Below is more information about it via a news release from\u00a0NORML:<\/p>\n
Hubei, China:<\/strong>\u00a0Adults with a history of cannabis use are less likely than non-users to be diagnosed with liver steatosis (abnormal fat retention a\/k\/a fatty liver disease), according to\u00a0data\u00a0published in the journal\u00a0PLOS One<\/em>.<\/p>\n A group of Chinese investigators assessed the relationship between marijuana use and the prevalence of fatty liver disease in a cohort of 2,622 US adults. Study participants consisted of current cannabis consumers, former consumers, and lifetime non-users.<\/p>\n Researchers determined that both current and former users possessed lower rates of liver steatosis than did those with no history of marijuana use \u2013 a finding that is consistent with\u00a0numerous\u00a0other\u00a0studies.<\/p>\n Authors of the study\u00a0concluded: \u201cIn this nationally representative sample, current marijuana use is inversely associated with steatosis. \u2026\u00a0Further studies are required to confirm these results longitudinally, and investigations into marijuana compounds and their biological effects are promising for treating and preventing fatty liver disease.\u201d<\/p>\n The results of a 2018\u00a0meta-analysis, which reviewed nine studies involving nearly six million subjects, similarly\u00a0acknowledged\u00a0\u201ca reduction in the prevalence of NAFLD (non-alcoholic fatty liver disease) in marijuana users.\u201d<\/p>\n Full text of the study, \u201cMarijuana use is inversely associated with liver steatosis detected by transient elastography in the general United States population in the NHANES 2017-2018: A cross-sectional study,\u201d appears in PLOS One.<\/em> This article first appeared on <\/em>Internationalcbc.com<\/em> and is syndicated here with special permission.<\/em><\/p>\n<\/p><\/div>\n